scispace - formally typeset
C

Christopher J L Murray

Researcher at Institute for Health Metrics and Evaluation

Publications -  833
Citations -  393064

Christopher J L Murray is an academic researcher from Institute for Health Metrics and Evaluation. The author has contributed to research in topics: Population & Mortality rate. The author has an hindex of 209, co-authored 754 publications receiving 310329 citations. Previous affiliations of Christopher J L Murray include Harvard University & University of Washington.

Papers
More filters
Journal ArticleDOI

Assessing the Burden of Disease in the United States Using Disability-Adjusted Life Years

TL;DR: This analysis provides the first detailed, comprehensive estimates using DALYs of the fatal and nonfatal conditions that exact large health burdens in the United States.
Journal ArticleDOI

Child and Adolescent Health From 1990 to 2015. Findings From the Global Burden of Diseases, Injuries, and Risk Factors 2015 Study

Nicholas J Kassebaum, +259 more
- 01 Jun 2017 - 
TL;DR: Global trends were driven by reductions in mortality owing to infectious, nutritional, and neonatal disorders, which in the aggregate led to a relative increase in the importance of noncommunicable diseases and injuries in explaining global disease burden.
Journal ArticleDOI

Changes in health in England, with analysis by English regions and areas of deprivation, 1990–2013: a systematic analysis for the Global Burden of Disease Study 2013

John N Newton, +92 more
- 05 Dec 2015 - 
TL;DR: In the Global Burden of Disease Study 2013 (GBDDS) as discussed by the authors, knowledge about health and its determinants has been integrated into a comparable framework to inform health policy.
Journal ArticleDOI

The global burden of neurological disorders: translating evidence into policy.

TL;DR: In the past 30 years, the absolute numbers of deaths and people with disabilities owing to neurological diseases have risen substantially, particularly in low-income and middle-income countries, and further increases are expected globally as a result of population growth and ageing.
Journal ArticleDOI

Modeling the impact of global tuberculosis control strategies

TL;DR: Support for major extensions to global tuberculosis control strategies will occur only if the size of the problem and the potential for action are recognized more widely and if a new vaccine with 50% efficacy could lower incidence and mortality.